This study presents TBorNotTB, a CDSS designed to improve TB evaluation and streamline isolation decisions, reducing labor ...

Abbott said under Operation Lone Star, state law enforcement has apprehended more than half a million undocumented immigrants, stopped more than 140,000 attempted "illegal entries," arrested over ...

Supporters say families should receive state support to send their child to a different school if public schools aren't ...

Abbott Laboratories posted lower-than-expected sales in its latest quarter despite growth across most of its segments, though shares rose as the company forecast strong earnings growth for 2025. The ...

Welcome to Abbott's fourth quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by ...

Abbott Laboratories posts total worldwide sales of $10.97 billion for the quarter ended Dec. 31, missing Wall Street ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve ...

For full-year 2025, the company forecast organic sales growth between 7.5% and 8.5% as well as adjusted earnings per share in the range of $5.05 and $5.25. Analysts polled by FactSet expect $42 ...

Robust Market Growth: The global rapid test readers market is projected to grow at a CAGR of 8.8% from 2023 to 2033, ...

Abbott's Diagnostics arm is expected to have been driven by the widespread adoption of its top-tier systems and high testing ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...